Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study.

Francesco PattiGiovanni Bosco ZimatoreVincenzo Brescia MorraUmberto AgugliaRoberto Bruno BossioRoberto MarzioloPaola ValentinoClara Grazia ChisariAntonio CapacchioneMario Zappianull null

Published in: Journal of neurology (2020)

IFN-β1a evening injections in the first 8 weeks of treatment led to an improvement in FLS; when continuing therapy, time of administration could be decided according to patient's lifestyle and preference.

Keyphrases

dendritic cells
metabolic syndrome
physical activity
immune response
cardiovascular disease
case report
electronic health record
big data
stem cells
ultrasound guided
medical education
data analysis
cell therapy